Getinge AB Class B · OMXSTO:GETI_B
Getinge AB Class B — Investor Day (2002)
37 slides from Getinge AB Class B's investor day presentation, 2002
Slide 1: Agenda
AGENDA n Market development and results 2001 n Group objectives and focus n Infection Control n Extended Care n Surgical Systems n Outlook
Slide 2: Market development and results
Market development and results
Slide 3: Getinge AB Results (MSEK)
Getinge AB Results (MSEK) 2001 2000 Change 2001 2000 Change Q4 Q4 12 Mon 12 Mon Orders received 2 318 1 461 59% 8 376 5 243 60% Net sales 2 457 1 633 50% 8 148 5 254 55% EBITDA 468 329 42% 1 341 892 50% Operating profit 374 278 36% 974 697 40% Operating margin 15,2% 17,0% 12,0% 13,3% Profit before t
Slide 4: Infection Control Orders received
Infection Control Orders received (MSEK) 2001 2000 Change 2001 2000 Change per market Q4 Q4 12 Mon12 Mon Western Europe 406 352 15% 1 465 1 271 15% USA and Canada 425 310 37% 1 451 1 170 24% Asia/Australia 95 66 44% 326 265 23% Rest of the world 71 44 62% 162 181 -10% Business area total 996 772 29%
Slide 5: Infection Control Results
Infection Control Results (MSEK) 2001 2000 2001 2000 Q4 Q 4 12 Mon 12 Mon Net sales 1 040 947 3 204 2 935 Gross margin % 39,2% 38,5% 36,0% 37,2% Operating cost -249 -209 -833 -722 Operating profit 159 156 321 369 Operating margin % 15,3% 16,5% 10,0% 12,6%
Slide 6: Extended Care Orders received
Extended Care Orders received (MSEK) 2 001 2 000 Change 2 001 2 000 Change per market Q4 Q4 12 Mon 12 Mon USA and Canada 256 214 19% 963 771 25% Great Britain 203 171 19% 737 569 30% Germany 65 60 7% 272 237 14% Other W Europe 168 159 5% 579 478 21% Rest of the world 27 23 17% 93 84 12% Business are
Slide 7: Extended Care Results
Extended Care Results (MSEK) 2001 2000 2001 2000 Q4 Q 4 12 Mon 12 Mon Net sales 762 634 2 656 2 111 Gross margin % 49,8% 49,5% 49,2% 49,4% Operating cost -241 -199 -886 -719 Operating profit 139 115 421 323 Operating margin % 18,2% 18,2% 15,9% 15,3%
Slide 8: Surgical Systems Orders received
Surgical Systems Orders received (MSEK) 2001 2000 2001 2000 per market Q4 Q4 12 Mon 12 Mon USA and Canada 135 44 428 129 Great Britain 25 0 116 Germany 127 0 591 Other Western Europe 184 2 621 2 Rest of the world 112 0 507 27 Business area total 583 45 2 263 158
Slide 9: Surgical Systems Results
Surgical Systems Results (MSEK) 2001 2000 2001 2000 Q4 Q4 12 Mon 12 Mon Net sales 635 37 2 223 147 Gross margin % 51,7% 39,1% 49,9% 30,3% Operating cost -253 -9 -881 -45 Operating profit 76 5 228 -1 Operating margin % 11,9% 13,9% 10,3% -0,7%
Slide 10: Group Objectives and Focus
_ Group Objectives and Focus 4 GETINGE
Slide 11: Getinge Group Objectives
Getinge Group Objectives Strategic n To develop world leading positions in prioritized niches of the health care industry
Slide 12: Strong Global Positions
Strong Global Positions Product line Position Market shares BA Infection Control Sterilization #1 24 % Disinfection #1 27 % BA Surgical Systems Surgical tables #1 40 % Surgical lights #1 38 % Ceiling units #3 I5 % BA Extended Care Hygiene Systems #1 55 % Patient Handling #1 39 % Wound Care #4 6%
Slide 13: Getinge Group Objectives
Getinge Group Objectives Strategic n To develop world leading positions in prioritized niches of the health care industry Financial n To increase profit before tax with an average of I5% per annum n Internally generated cash flow to sustain an external growth rate of I0% per annum
Slide 14: The Getinge Group
The Getinge Group 9000 800 8000 700 7000 600 6000 500 5000 400 4000 300 3000 2000 200 1000 100 0 0 1993 1994 1995 1996 1997 1998 1999 2000 2001 Invoiced sales Profit before tax
Slide 15: Group Mission
Group Mission positive outcomes A competent systems provider in well defined niches of the health care industry offering solutions that enhance customers’ productivity and quality of care over time
Slide 16: Group Focus 2002 - 2004
Group Focus 2002 - 2004 Infection Control To create a customer focused group from a federation of companies acquired over the last I0 years Extended Care Focus on growth from a solid platform through product innovation, market penetration and geographical expansion Surgical Systems To create a globa
Slide 17: Review of Business Areas
Review of Business Areas ee 4 GETINGE
Slide 18: Infection Control - Health Care
Infection Control - Health Care Disinfection Sterilization IT-solutions Load handling
Slide 19: Infection Control - Industry
Infection Control - Industry Sterilization Washing Water Treatment Load Handling
Slide 20: Moving up the Value chain
Moving up the Value chain Sterilizer Sterilizer Disinfector Disinfector Complete Load Load handling handling Service Service Infection Logistics Logistics Provider Provider Consumables Consumables Control Information Concept Concept Information Solution Management Management After After Sales Sales
Slide 21: Key Activities 2002 - 2003
Key Activities 2002 - 2003 n Position the Getinge brand as a competent solutions provider n Improved production structure n Organizational focus n Increased focus on R & D - low temp solutions - material handling - ergonomy n Service expansion
Slide 22: Business Area Extended Care
Business Area Extended Care Hygiene Systems Patient Handling Wound Care
Slide 23: Focus on Growth
Focus on Growth n Increased market penetration
Slide 24: Market Penetration - Major Markets
Market Penetration* - Major Markets sek 2500 2000 1500 Sales per bed 1000 500 0 NL CAN UK DE US IT FR *) Sales of Patient Handling and Hygiene Systems product per institutional care bed
Slide 25: Focus on Growth
Focus on Growth n Increased market penetration n Geographical expansion - Japan - Emerging markets n Marketing / training programs
Slide 26: Positive Outcomes Programs
Positive Outcomes Programs Corpus Facility assessment and tailored training programs for long term care facilities Diligence 3 - 4 years comprehensive equipment and training program with guaranteed reduction in work related injuries Guidebook for architects A support for achitects and planners in de
Slide 27: Focus on Growth
Focus on Growth n Increased market penetration n Geographical expansion - Japan - Emerging markets n Marketing / training programs n Product development - range extension n Cross-selling wound care
Slide 28: Surgical Systems
Surgical Systems Surgical Tables Surgical Lights Ceiling Service Systems
Slide 29: Strategic Cornerstones
Strategic Cornerstones n Technological leadership n Integrated solutions n Excellence in service
Slide 30: Restructuring Program
Restructuring Program Divestiture of OrtoMaquet Production Closure of production facilities in Charleston USA and Oer-Erkenschwick Germany Distribution Merger of sales activities in Germany, USA, UK, France, Italy, Spain, Japan and International Reduced overhead costs Synergies of I40 - I50 MSEK ann
Slide 31: Heraeus Medical Technology Highlights
Heraeus Medical Technology Highlights n Market shares in surgical lighting and ceiling service units will be strongly enhanced n Improved geographical coverage n Enhanced product range n Strong contribution to group and business area earnings from 2003
Slide 32: Growth Opportunities in Surgical Systems
Growth Opportunities in Surgical Systems n Product development initiatives n Market penetration tables USA + Japan I5 --> 30% market shares --> 250 MSEK+ n Cross-selling opportunities in most markets n Own sales companies in major markets n Active participation in the consolidation of the surgical s
Slide 33: Expansion Possibilities within Surgical Systems Markets
Expansion Possibilities within Surgical Systems Markets Surgical Instruments Anaesthesia Disposables Monitoring Surgical Navigation Robotics Procedures Ancillary Imaging Equipment Life Support
Slide 34: Outlook
4 GETINGE
Slide 35: Outlook
Outlook Infection Control - Good order book + 50 % (30%) - Good market conditions in North America and in emerging markets - Improving manufacturing structure Extended Care - Market prospects remain strong - Strong product portfolio - Focus on growth Surgical Systems - Good order book - Incremental
Slide 36: Getinge is well positioned - Short term
Getinge is well positioned Short term n Turnaround in the earnings trend for Infection Control n Good overall order situation and market outlook for all business areas n Incremental synergies in Surgical Systems n Improving capital utilization
Slide 37: Getinge is well positioned - Long term
Getinge is well positioned Long term n Strong market fundamentals in Extended Care n Significant scope for improvement in operating performance within Infection Control n Opportunities for growth through acquisitions in a fragmented surgical systems market